Yayın:
Ceftriaxone and Phenylalanine Combination as Broad Spectrum Antimicrobials Therapy

dc.contributor.authorSayiner, Hakan Sezgin
dc.contributor.authorGanim, Mohamed Abdulhamid
dc.contributor.authorAltunoglu, Yasemin Celik
dc.contributor.authorBaloglu, Mehmet Cengiz
dc.contributor.authorKandemirli, Fatma
dc.date.accessioned2026-01-03T10:10:35Z
dc.date.issued2017-09-25
dc.description.urihttps://doi.org/10.2174/1574885512666170609125312
dc.description.urihttps://dx.doi.org/10.2174/1574885512666170609125312
dc.identifier.doi10.2174/1574885512666170609125312
dc.identifier.issn1574-8855
dc.identifier.openairedoi_dedup___::726bad2048611522396d2cb12647f2f5
dc.identifier.orcid0000-0002-2056-794x
dc.identifier.scopus2-s2.0-85032970702
dc.identifier.urihttps://hdl.handle.net/20.500.12597/36535
dc.identifier.volume12
dc.identifier.wos000447560000005
dc.language.isoeng
dc.publisherBentham Science Publishers Ltd.
dc.relation.ispartofCurrent Drug Therapy
dc.titleCeftriaxone and Phenylalanine Combination as Broad Spectrum Antimicrobials Therapy
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Hakan Sezgin Sayiner","name":"Hakan Sezgin","surname":"Sayiner","rank":1,"pid":null},{"fullName":"Mohamed Abdulhamid Ganim","name":"Mohamed Abdulhamid","surname":"Ganim","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0002-2056-794x"},"provenance":null}},{"fullName":"Yasemin Celik Altunoglu","name":"Yasemin Celik","surname":"Altunoglu","rank":3,"pid":null},{"fullName":"Mehmet Cengiz Baloglu","name":"Mehmet Cengiz","surname":"Baloglu","rank":4,"pid":null},{"fullName":"Fatma Kandemirli","name":"Fatma","surname":"Kandemirli","rank":5,"pid":null}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"FOS","value":"0302 clinical medicine"},"provenance":null},{"subject":{"scheme":"FOS","value":"02 engineering and technology"},"provenance":null},{"subject":{"scheme":"FOS","value":"0210 nano-technology"},"provenance":null}],"mainTitle":"Ceftriaxone and Phenylalanine Combination as Broad Spectrum Antimicrobials Therapy","subTitle":null,"descriptions":null,"publicationDate":"2017-09-25","publisher":"Bentham Science Publishers Ltd.","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":null,"container":{"name":"Current Drug Therapy","issnPrinted":"1574-8855","issnOnline":null,"issnLinking":null,"ep":null,"iss":null,"sp":null,"vol":"12","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::726bad2048611522396d2cb12647f2f5","originalIds":["LiveAll1","10.2174/1574885512666170609125312","50|doiboost____|726bad2048611522396d2cb12647f2f5","2758443287"],"pids":[{"scheme":"doi","value":"10.2174/1574885512666170609125312"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":0,"influence":2.5349236e-9,"popularity":9.502324e-10,"impulse":0,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C5"}},"instances":[{"pids":[{"scheme":"doi","value":"10.2174/1574885512666170609125312"}],"type":"Article","urls":["https://doi.org/10.2174/1574885512666170609125312"],"publicationDate":"2017-09-25","refereed":"peerReviewed"},{"alternateIdentifiers":[{"scheme":"mag_id","value":"2758443287"},{"scheme":"doi","value":"10.2174/1574885512666170609125312"}],"type":"Article","urls":["https://dx.doi.org/10.2174/1574885512666170609125312"],"refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Koleksiyonlar